Literature DB >> 3054312

Nonimmunologic mechanisms of glomerular injury.

J L Olson1, R H Heptinstall.   

Abstract

From the above discussion it is clear that many factors have been invoked in the pathogenesis of progressive glomerular injury. Those which are most important include increased PGC, coagulation, serum lipid abnormalities, and hypertrophy. Although many hemodynamic alterations have been identified, increased PGC was noted most constantly. Furthermore, the loss of autoregulatory capability which was observed in some models with progressive glomerulosclerosis usually resulted in increased PGC. Increased PGC has been associated with augmented dietary protein and is seen in the Munich-Wistar rat made diabetic. Such an increase in PGC could cause direct mechanical injury to endothelial and epithelial cells, as well as be responsible for increased mesangial traffic of macromolecules with the potential for stimulating cellular proliferation and mesangial matrix increase. Additional support for the importance of increased PGC is provided by the protective effect of decreasing PGC with CEI therapy and anemia, and by the enhanced autoregulatory capability in both the Milan and Okamoto hypertensive rats. The significance of coagulation factors is confirmed by the formation of platelet and fibrin thrombi in the development of the glomerular lesions. The sequence of glomerular injury suggests that endothelial damage occurs with subsequent formation of platelet aggregates as a response to this injury. Formation of platelet aggregates may be associated with the production of substances potentially injurious to the endothelial cells. Although blocking the appearance of such thrombi by administration of heparin or thromboxane synthetase inhibitor prevents glomerular injury, the blood pressure lowering effect of these agents complicates the interpretation of the studies. Serum lipid abnormalities are also important factors in the progression of nonimmunologic glomerular injury. Such abnormalities are observed with increased dietary phosphorus or lipid, in the obese Zucker rat, and in rats with diabetes mellitus. Reduction in serum cholesterol by administration of clofibric acid or mevinolin diminishes glomerular injury independent of alterations in glomerular hemodynamics. The possible link between increased serum lipids and augmentation of glomerular injury is at present indirect. The importance of hypertrophy as a contributing factor to the progression of nonimmunologic glomerular injury is suggested by several lines of evidence. Hypertrophy, with increase in glomerular size and caliber of capillary loops, may amplify the effect of increased PGC by further intensifying the tension and mechanical stress on all elements of the capillary wall.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054312

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  Polycythemia vera and glomerulonephritis in a dog.

Authors:  A D Quesnel; S A Kruth
Journal:  Can Vet J       Date:  1992-10       Impact factor: 1.008

2.  Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats.

Authors:  P L Miller; J W Scholey; H G Rennke; T W Meyer
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Prevention of 11-deoxycorticosterone-salt-induced glomerular hypertrophy and glomerulosclerosis by dietary phosphate binder.

Authors:  T Shimamura
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

4.  Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy.

Authors:  Nobuo Tsuboi; Tetsuya Kawamura; Kentaro Koike; Hideo Okonogi; Keita Hirano; Akihiko Hamaguchi; Yoichi Miyazaki; Makoto Ogura; Kensuke Joh; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

Review 5.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

6.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.

Authors:  I Shirato; T Sakai; K Kimura; Y Tomino; W Kriz
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.

Authors:  R A Lafayette; G Mayer; S K Park; T W Meyer
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Intraglomerular expression of transforming growth factor-beta 1 (TGF-beta 1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction.

Authors:  M Iwano; Y Akai; Y Fujii; Y Dohi; N Matsumura; K Dohi
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

9.  Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.

Authors:  Richard Torres; Heino Velazquez; John J Chang; Michael J Levene; Gilbert Moeckel; Gary V Desir; Robert Safirstein
Journal:  J Am Soc Nephrol       Date:  2015-08-24       Impact factor: 10.121

10.  Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat.

Authors:  B L Riser; P Cortes; X Zhao; J Bernstein; F Dumler; R G Narins
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.